Sponsor

Teva Neuroscience, Inc.

Clinical research sponsor

Published trials15
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

15 shown
Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) PatientsNCT01167426 · lead sponsor · 2010-07-01
COMPLETED
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's DiseaseNCT01049984 · lead sponsor · 2009-12-01
COMPLETED
Therapy Optimization in Multiple Sclerosis (MS)NCT00819000 · lead sponsor · 2008-12-01
COMPLETED
A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's DiseaseNCT00399477 · lead sponsor · 2006-10-01
COMPLETED
A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® AloneNCT00240006 · lead sponsor · 2006-01-01
COMPLETED
A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®NCT00239993 · lead sponsor · 2005-08-01
COMPLETED
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.NCT00220922 · lead sponsor · 2004-08-01
COMPLETED
A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® TherapyNCT00238654 · lead sponsor · 2003-05-01
COMPLETED
Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With LevodopaNCT00203060 · lead sponsor · 1997-07-01
COMPLETED
A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic TherapyNCT01497652 · collaborator · 2012-01-01
COMPLETED
Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer AcetateNCT01454791 · collaborator · 2011-01-01
COMPLETED
A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's PatientsNCT01007630 · collaborator · 2009-11-01
UNKNOWN
ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease SubjectsNCT00936676 · collaborator · 2009-07-01
COMPLETED
Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple SclerosisNCT00819195 · collaborator · 2008-12-01
COMPLETED
Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)NCT00937157 · collaborator · 2007-09-01
COMPLETED

Sponsor roles

lead sponsor9
collaborator6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.